Denteric: is developing therapeutic treatments for chronic inflammation caused by bacterial toxins from Porphyromonas gingivalis infections. A Phase 1 trial is in progress for Alzheimer's disease and we are planning for Ph 2 studies in severe periodontal disease.

Why work with us

We are a first in class treatment for chronic inflammation caused by periodontal disease that aims to modify disease by generating antibodies to neutralise bacterial toxins in the mouth and circulating systemically. Standard of care is antibiotics or manual scraping by a dental professional which is painful and costly and does not address the cause of inflammation - the bacterial toxins. This treatment will have oral and systemic nenefits